The European Respiratory Journal
European Respiratory Society
COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?
DOI 10.1183/13993003.01645-2020, Volume: 56, Issue: 1,

Table of Contents




Absolute cessation of any tobacco product in any form: implications for COVID-19

McAlinden, Eapen, Lu, Chia, Haug, and Sohal: COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?

To the Editor:

With great interest we read and commend the study done by Russoet al. [1], highlighting their findings that nicotine induces an increase in angiotensin-converting enzyme 2 (ACE-2) expression in human bronchial epithelial cells (HBEpC) and is mediated by α7-subtype nicotinic receptors (α7-nAChR). It raises the concern that all electronic nicotine-delivery systems may put users at greater risk of succumbing to coronavirus disease 2019 (COVID-19).

We [2], along with Leunget al . [3], have shown that ACE-2 expression is upregulated in the small airway epithelia of smokers and patients with COPD. In particular, we observed increased ACE-2 expression in type-2 pneumocytes and alveolar macrophages along with the small airway epithelium of smokers compared to healthy never-smokers [2]. Similar studies are yet to be done in the context of electronic cigarettes (e-cigarettes), heat-not-burn devices (IQOS) or waterpipe exposure to human airways. ACE-2 is the binding site for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mediating entry of the virus into cells [4]. Binding affinity between the spike proteins of the virus and ACE-2 on respiratory cells has been identified to be much higher than any previously identified human coronavirus. The significance of such overexpression of ACE-2 in smokers should not be ignored. COVID-19 and progression of severe pneumonia may be more likely to occur in smokers, particularly in those that have smoking-related comorbidities [5]. We are beginning to elucidate the role of traditional cigarette smoking and nicotine-driven changes to the lungs in the context of coronavirus transmission and susceptibility. Cigarette smoke has been identified and linked to increasing expression of the binding site for the cause of the 2020 pandemic (SARS-CoV-2) via mediating nicotine receptors. With this, an avoidable and potentially gigantic risk-factor has emerged for COVID-19, as the pandemic continues to claim ultimate grasp over the year of 2020.

Here, we bring to the discussion whether the increased susceptibility and virulence of SARS-CoV-2 via α7-nAChR and the upregulation of small airway ACE-2 expression may also be relevant for those who vape using nicotine-based e-cigarettes. E-cigarette vapour studies, although in their infancy, have already shown that they can enhance the virulence and inflammatory profile of pathogens such as Streptococcus pneumoniae , among other deleterious biological effects [6]. Vaping intensifies pneumococcal adherence through an increase in platelet-activating factor receptor expression, ultimately rendering those who vape with an increased risk of pneumonia [7, 8]. We, among others, have previously shown that e-cigarettes and IQOS are not “safer”, as having a vast pro-inflammatory response [9]. We compared cigarette smoke versus e-cigarette and IQOS on airway epithelial and smooth muscle cells [9]. All tested pathological biomarkers were elevated in cells exposed to e-cigarette aerosols and IQOS, which included chemokine CXCL8, extracellular matrix proteins and markers of mitochondrial dysfunction. We found these products toxic to the cells, evident from decreased cellular viability and integrity. More devastatingly, vaping also interfered with cellular energetics. Our results further substantiate current research that e-cigarettes and IOQS are indeed detrimental with increases in oxidative stress, inflammation, infections and airway remodelling in the lungs of these device users. As the scientific evidence mounts, confirming the fears that e-cigarettes and IQOS are strongly associated with the development and progression of debilitating lung diseases [10], now may be the prime time to include all electronic nicotine delivery systems in the vocalisation of concerns concerning tobacco-related death and disease.

We recirculate the simple notion that the lungs are not designed for the chronic inhalation of anything but air and that the indication for a smoking- and nicotine-induced increase in ACE2 is more evidence to the stacking weight of toxicity that tobacco is for humanity. Given the role of the nicotine receptor, vaping may also lead to the upregulation of ACE-2. Research in this area will be invaluable in the development of e-cigarette research and providing trusted, peer-reviewed and real evidence for the youth of the 2020s. We strongly recommend that the World Health Organization and countries act to advance their efforts to reduce smoking, vaping and waterpipe use. During a pandemic it is difficult to focus on anything other than the immediate threat. The “primacy of rescue” has overwhelmed preventive action. Additional research into the relationship of smoking, and all electronic nicotine delivery systems to the infection, transmission and progression of COVID-19 is required. Progress towards easily identifying those susceptible to severe disease or capable of asymptomatic transmission are important goals for managing the disease at a community level. COVID-19 is a dress rehearsal for the next pandemic, and the next, and the one after that: the new norm.

Shareable PDF


This one-page PDF can be shared freely online.

Shareable PDF ERJ-01645-2020.Shareable


Clifford Craig Foundation Launceston General Hospital, Rebecca L. Cooper Medical Research Foundation.


Conflict of interest: K.D. McAlinden has nothing to disclose.
Conflict of interest: M.S. Eapen has nothing to disclose.
Conflict of interest: W. Lu has nothing to disclose.
Conflict of interest: C. Chia has nothing to disclose.
Conflict of interest: G. Haug has nothing to disclose.
Conflict of interest: S.S. Sohal has nothing to disclose.



    Russo P, Bonassi S, Giacconi R, et al.. COVID-19 and smoking: is nicotine the hidden link?Eur Respir J2020; 55: , pp.2001116. doi:, doi: 10.1183/13993003.01116-2020


    Brake SJ, Barnsley K, Lu W, et al.. Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19). J Clin Med2020; 9: , pp.841. doi:, doi: 10.3390/jcm9030841


    Leung JM, Yang CX, Tam A, et al.. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J2020; 55: , pp.200688. doi:, doi: 10.1183/13993003.00688-2020


    Wrapp D, Wang N, Corbett KS, et al.. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science2020; 367: , pp.1260–1263. doi:, doi: 10.1126/science.abb2507


    Liu W, Tao Z-W, Wang L, et al.. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J2020; 133: , pp.1032–1038.


    Gilpin DF, McGown KA, Gallagher K, et al.. Electronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens. Respir Res2019; 20: , pp.267. doi:, doi: 10.1186/s12931-019-1206-8


    Miyashita L, Suri R, Dearing E, et al.. E-cigarette vapour enhances pneumococcal adherence to airway epithelial cells. Eur Respir J2018; 51:, pp.1701592. doi:, doi: 10.1183/13993003.01592-2017


    Atto B, Eapen MS, Sharma P, et al.. New therapeutic targets for the prevention of infectious acute exacerbations of COPD: role of epithelial adhesion molecules and inflammatory pathways. Clin Sci2019; 133: , pp.1663–1703. doi:, doi: 10.1042/CS20181009


    Sohal SS, Eapen MS, Naidu VGM, et al.. IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette. ERJ Open Res2019; 5: , pp.00159-2018. doi:, doi: 10.1183/23120541.00159-2018


    McAlinden KD, Sohal SS, Sharma P. There can be smoke without fire: warranted caution in promoting electronic cigarettes and heat not burn devices as a safer alternative to cigarette smoking. ERJ Open Res2019; 5: , pp.00114-2019. doi:, doi: 10.1183/23120541.00114-2019 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?&author=Kielan Darcy McAlinden,Mathew Suji Eapen,Wenying Lu,Collin Chia,Greg Haug,Sukhwinder Singh Sohal,&keyword=&subject=Agora,Correspondence,